There are both promising therapies and emerging problems in the future management of cystic fibrosis, according to a UK paediatric respiratory physician. Dr Ian Balfour-Lynn, director of paediatric CF at the Royal Brompton Hospital, told ERS 2018 that phase 2 studies of CFTR modulating therapies showed they had a ‘genuine disease modifying effect’. As a ...
Already a member?
Enter your email to keep reading.